Astera Labs, Inc.'s results for Q3 2026 (ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-11-03. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.
At a glance
| Item | Value |
|---|---|
| Revenue (GAAP) | $585 million (+153.7% vs a year earlier) |
| Diluted EPS (GAAP) | $0.99 |
| Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs) | $1.32 |
| Full-year guidance | Next quarter only |
Guidance
Guides Q4 2026 revenue of $730–$750 million and non-GAAP diluted EPS of about $1.62–$1.66; no full-year outlook.
Why this label: Outlook covers only Q4 2026 (revenue $730-$750M, EPS); no full-year figures.
Next-quarter outlook:
| Metric | Period | Range |
|---|---|---|
| revenue | Q4 2026 | $730–$750 million |
| non-GAAP diluted EPS | Q4 2026 | approximately $1.62–$1.66 |
| GAAP diluted EPS | Q4 2026 | approximately $1.13–$1.17 |
From the release
Revenue: "Revenue of $584.9 million, up 49% sequentially and up 154% year-over-year"
Earnings per share: "GAAP diluted net income per share of $0.99"
Key fact: Record revenue $584.9 million, up 154% y/y; Q4 revenue guided $730–750 million.
Source
Astera Labs, Inc. earnings release (SEC filing), accession 0001736297-26-000044, filed 2026-11-03.
Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.